Nucleic acids encoding complement component C5 antibodies
US9932395B2 · kind B2 · utility
1Cited by
34References
2Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 10, 2017 |
| Grant date | Apr 3, 2018 |
| Priority date | — |
| Expiry date | Jul 10, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to antibodies and polynucleotides encoding the same, that may be used to prevent, control, or reduce the activity of the complement pathway. In addition, the disclosure is directed to compositions and methods for diagnosing and treating diseases mediated by or involving complement C5. Specifically, the disclosure is related to C5 antibodies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.